Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).
Florian LiégeoisSylvie BoyerSabrina Eymard-DuvernayPatrizia CarrieriCharles KouanfackJenny DomyeumGwenaëlle MaradanJacques DucosEitel Mpoudi-NgoléBruno SpireEric DelaporteChristopher KuabanLaurent VidalChristian Laurentnull nullPublished in: BMC infectious diseases (2020)
A substantial proportion of HIV/HBV coinfected patients were at higher risk of liver disease progression. Improving the management of HBV infection in the routine healthcare setting in Africa is urgently required in order to achieve the 2030 elimination targets. Micro-elimination of HBV infection in people living with HIV could be an easier and cost-effective component than more widely scaling up HBV policies.
Keyphrases
- hepatitis b virus
- antiretroviral therapy
- hiv infected patients
- liver failure
- hiv infected
- healthcare
- hiv positive
- end stage renal disease
- human immunodeficiency virus
- hiv aids
- ejection fraction
- chronic kidney disease
- public health
- prognostic factors
- hepatitis c virus
- patient reported outcomes
- social media
- smoking cessation